61 Biggest Movers From Yesterday
$AI
$ATNF
$BYSI
$CNTX
Computer Software: Prepackaged Software
Technology
Biotechnology: Pharmaceutical Preparations
Health Care
Check out these big penny stock gainers and losers
Losers
- Tantech Holdings Ltd (NASDAQ:TANH) fell 57% to close at $0.6450 after the company priced 21,120,509 share common stock offering at $0.65 per share.
- Kirkland's, Inc. (NASDAQ:KIRK) shares dipped 24.8% to settle at $15.48 after the company reported worse-than-expected Q3 results.
- 180 Life Sciences Corp. (NASDAQ:ATNF) dipped 23.6% to settle at $3.86 after dipping more than 20% on Wednesday.
- Grab Holdings Limited (NASDAQ:GRAB) fell 20.5% to settle at $8.75. Grab Holdings completed its earlier announced business combination with Altimeter Growth, a special purpose acquisition company.
- Context Therapeutics Inc. (NASDAQ:CNTX) declined 20% to close at $5.73 after the company announced a private placement of $31.25 million. The placement includes 5 million shares together with warrants to purchase 5 million shares.
- NLS Pharmaceutics AG (NASDAQ:NLSP) dipped 18% to close at $1.64.
- MDJM Ltd (NASDAQ:MDJH) shares declined 17.1% to close at $2.42 after jumping 14% on Wednesday.
- OceanPal Inc. (NASDAQ:OP) shares dropped 16.7% to close at $5.45. OceanPal shares gained 25% on Wednesday after completion of spinoff from Diana Shipping on Tuesday.
- Eliem Therapeutics, Inc. (NASDAQ:ELYM) dipped 16.5% to settle at $11.34.
- The Vita Coco Company, Inc. (NASDAQ:COCO) fell 16.3% to close at $11.07.
- Novavax, Inc. (NASDAQ:NVAX) dropped 15.9% to close at $161.97 despite reports the company has initiated development of an omicron-specific vaccine construct. Vaccine makers have been volatile amid uncertainty over omicron variant effectiveness.
- nCino, Inc. (NASDAQ:NCNO) fell 15.6% to settle at $49.88 following Q3 results.
- Elastic N.V. (NYSE:ESTC) dipped 15% to close at $118.28 after the company reported Q2 earnings results and issued Q3 and FY22 guidance.
- Vaxxinity, Inc. (NASDAQ:VAXX) dipped 14.5% to settle at $9.35.
- Journey Medical Corporation (NASDAQ:DERM) fell 14.5% to settle at $6.75.
- Finch Therapeutics Group, Inc. (NASDAQ:FNCH) dropped 14% to close at $14.51. Finch Therapeutics Group, last month, posted a Q3 loss of $0.21 per share.
- Skylight Health Group Inc. (NASDAQ:SLHG) fell 13.5% to close at $1.47 after jumping over 28% on Wednesday.
- EHang Holdings Limited (NASDAQ:EH) dipped 13.5% to close at $16.81. EHang Holdings reported a third-quarter revenue increase of 6.6% year-over-year to RMB13 million ($2 million).
- Katapult Holdings, Inc. (NASDAQ:KPLT) dropped 13.4% to settle at $3.17. The Company booked Gross Originations from October 1, 2021, through November 30, 2021, of $40.4 million.
- VBI Vaccines Inc. (NASDAQ:VBIV) shares declined 13.1% to settle at $2.71. The FDA recently approved VBI Vaccines’ PreHevbrio [Hepatitis B Vaccine (Recombinant)] to prevent the infection caused by all known subtypes of hepatitis B virus (HBV) in adults age 18 years and older.
- Xilio Therapeutics, Inc. (NASDAQ:XLO) dipped 12.5% to close at $14.19 after reporting a Q3 loss of $21.27 per share.
- C3.ai, Inc. (NYSE:AI) fell 11.2% to close at $30.04. Analysts lowered their price targets on C3.ai following the Q2 results.
- Hut 8 Mining Corp. (NASDAQ:HUT) dropped 11% to settle at $10.49.
- MEI Pharma, Inc. (NASDAQ:MEIP) fell 10.7% to close at $2.70 after the company reported pricing of public offering of common stock.
- BeyondSpring Inc. (NASDAQ:BYSI) fell 9.9% to close at $4.44 after Jefferies downgraded the stock from Buy to Hold and lowered the price target from $38 to $5.
- BeyondSpring recently received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the plinabulin NDA for prevention of chemotherapy-induced neutropenia.
- Lands' End, Inc. (NASDAQ:LE) fell 9.9% to close at $19.76 after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below estimates.
- NerdWallet, Inc. (NASDAQ:NRDS) fell 8.7% to close at $16.18.
- ReneSola Ltd (NYSE:SOL) fell 7.6% to close at $6.06. 'We believe ReneSola is a Fraudulent Company; Most Projects Never Existed' -short report from Grizzly Research.
- The GEO Group, Inc. (NYSE:GEO) fell 6.7% to close at $7.56.
- Delcath Systems, Inc. (NASDAQ:DCTH) fell 6% to close at $9.13 after the company announced Phase 3 FOCUS trial results for hepzato in liver-dominant metastatic ocular melanoma, including initial survival data analysis.
- NuZee, Inc. (NASDAQ:NUZE) shares fell 5.3% to close at $3.61 after declining 18% on Wednesday.